Microbot Medical Inc. (MBOT) vs Nyxoah SA (NYXH)
Microbot Medical Inc. and Nyxoah SA are both Medical Instruments & Supplies companies. Nyxoah SA is the larger, with a market value of $129.3M against $88.0M — 1.5× the size. Nyxoah SA grew revenue faster over the last twelve months: 366.2% against −59.1%. Nyxoah SA has the higher net margin (−446.4% vs −3,955.2%) and the higher return on invested capital (−117.8% vs −850.5%). Across the 18 metrics below, Nyxoah SA leads on 11 and Microbot Medical Inc. on 7.
Valuation
Profitability
| Metric | MBOT | NYXH | Medical Instruments & Supplies median |
|---|---|---|---|
| Gross margin | (166.30%) | 60.16% | 54.62% |
| Operating margin | (4,480.03%) | (391.25%) | 1.64% |
| Net margin | (3,955.22%) | (446.39%) | 0.00% |
| Free cash flow margin | (4,340.11%) | (344.99%) | 1.61% |
| Return on equity | (32.91%) | (124.41%) | 0.00% |
| Return on assets | (30.68%) | (68.23%) | 0.00% |
| Return on invested capital | (850.51%) | (117.82%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack